PMDA drug package insert
マグミット錠100mg
PMDA Prescription drug · マグミット製薬株式会社 · package insert Sep 7, 2026
Key facts
| Brand names | マグミット錠100mg, マグミット錠250mg, マグミット錠330mg, マグミット錠500mg |
|---|---|
| Nonproprietary names | 酸化マグネシウム |
| Companies | 製造販売元／マグミット製薬株式会社, 販売元／株式会社フェルゼンファーマ |
| Product type | Prescription drug |
| Therapeutic category | 制酸・緩下剤 |
| Therapeutic category codes | 872344, 872355 |
| YJ codes | 2344009F7025, 2344009F1035, 2344009F2031, 2344009F4034 |
| Approval numbers | 30700AMX00202, 21400AMZ00375, 21400AMZ00374, 21700AMZ00813 |
| Package insert edition | 第4版 |
| Package insert date | Sep 7, 2026 |
| PMDA document key | 731040_2344009F1035_B |
| PMDA company code | 731040 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: